- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2017-06
2019-06
2019-06
30
NCT03178812
Hillel Yaffe Medical Center
Hillel Yaffe Medical Center
INTERVENTIONAL
Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS)
This study aims to find a correlation between cytokines levels and malignancy potential of different cystic types.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2017-05-10 | N/A | 2017-06-05 |
2017-06-05 | N/A | 2017-06-07 |
2017-06-07 | N/A | 2017-06 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Diagnostic
Allocation:
Non Randomized
Interventional Model:
Parallel
Masking:
None
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| ACTIVE_COMPARATOR: Patients with pancreatic cysts Fine-needle aspiration (FNA) by Endoscopic Ultrasound (EUS) will collect liquid from patients' pancreatic cysts to measure their Interleukin and TNF levels | PROCEDURE: EUS with fine-needle aspiration of pancreatic cyst
|
| ACTIVE_COMPARATOR: Healthy volunteers Laboratory blood test to measure Interleukin and TNF levels | PROCEDURE: EUS with fine-needle aspiration of pancreatic cyst
DIAGNOSTIC_TEST: Laboratory Blood test
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Prediction of malignant potential of pancreatic cyst by measuring Interleukin levels | Interleukin 1,8,10 will be measured quantitatively by an enzyme-linked immunosorbent assay. The same interleukins levels will be measured in serum of same patients and control group. Results will enable classification of cysts to either high or low risk malignancy potential. | Two years |
| Prediction of malignant potential of pancreatic cyst by measuring TNF levels | TNF levels will be measured quantitatively by an enzyme-linked immunosorbent assay. The same TNF levels will be measured in serum of same patients and control group. Results will enable classification of cysts to either high or low risk malignancy potential. | Two years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
|
Study Contact Name: Yael Kopelman, MD Phone Number: 972-50-6246840 Email: yaelk@hy.health.gov.il |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
1
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
